The Next Frontier in the Treatment of Clinical Depression.

As we learn more about the different pathways and brain regions that are involved in depression and anxiety, the monoamine hypotheses is no longer enough.  Neuromodulation or medications that promote neuroplasticity is the future of psychiatric treatment.  In my opinion, what we are seeing is a revolution much akin to when Prozac was discovered and it will change the way we treat mental illness.